HOME >> BIOLOGY >> NEWS
Federal testing for mad cow disease a failure, law review editor says

gency and the beef industry from a public outcry that would take place if more cases of mad cow disease were found. "In its 93 years of existence, the Virus-Serum-Toxin Act has never been used or interpreted to regulate testing of any kind. Manipulating the act to include the BSE test perverts the statute's purpose."

Congress should pass legislation forcing the USDA to license BSE tests to ranchers and slaughterhouses. "The USDA should create standards for testing conditions and requirements, and promulgate an application process with objective criteria for private producers. A standard testing regime would enable private producers such as Creekstone to market their beef as 'tested for BSE.'"

Berlowitz cited news reports that the cost of such testing would add only 6 to 10 cents to a pound of beef.

His article further warns of poor oversight of cattle feed. In particular, the slaughterhouse practice of "rendering," or recycling dead cows and sheep into protein for cattle feed, is believed to be widespread.

Congress banned the practice in 1997 following evidence that feeding herbivorous cows the meat from dead animals can lead to the formation of abnormal proteins, or prions.

The prions attack a cow's brain tissue, causing holes to form. As the brain loses function, the cow becomes disoriented and clumsy. Eventually the animal loses all muscle control and is unable to walk or eat. No treatment is available.

Enforcement of cattle-feed restrictions was placed in the hands of the Food and Drug Administration (FDA) rather than the USDA, which has caused various bureaucratic snarls, including a lack of communication between the two agencies.

"The FDA is far behind on inspecting feed businesses subject to the feed ban, has no uniform plan to identify feed businesses, has no routine procedure for testing of cattle feed, does not require a notice about the ban to be placed on feed, and has repeatedly failed to noti
'"/>

Contact: Mark Reutter, Business & Law Editor
mreutter@uiuc.edu
217-333-0568
University of Illinois at Urbana-Champaign
15-May-2006


Page: 1 2 3 4

Related biology news :

1. SNM opposes new payment caps on imaging services detailed in Federal Deficit Reduction Act
2. Pioneering ecologist Ruth Patrick honored by Federal-State Commission
3. ORNL technologies win maximum Federal Laboratory Consortium awards
4. Federal/private partners launch resource for diabetic kidney disease gene studies
5. Modular leukemia drug shows promise in early testing
6. Rapid syphilis testing in Haiti will prevent congenital disease and stillbirths
7. XDx to present recent success with AlloMap molecular expression testing
8. Potential genetic testing for substance abuse raises hope, concern
9. U-M team: Genetic testing sheds light on degenerative eye disease
10. Antiretroviral resistance testing in HIV infected patients improves health and saves costs
11. Professors to develop hand-held pathogen testing device

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... and GAITHERSBURG, Md. ... MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics ... of a definitive agreement for the merger of ... current investors include Novartis Venture Fund, HealthCap, Truffle ... be a fully-integrated and diversified immunotherapeutics company with ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
(Date:1/19/2017)... Ca (PRWEB) , ... January 18, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, was today ... News. The awards program is based entirely on merit and decided upon by ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... services spanning the full spectrum of drug and device development, and Prism ... pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has ...
Breaking Biology Technology:
Cached News: